Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...

neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...

Brukers market-leading MALDI system - the first MALDI-TOF/TOF that adapts to your needs The rapifleX is the most advanced MALDI TOF/TOF system on the market today and it is also the most adaptable.

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure MALDI PharmaPulse is a complete mass ...

The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...

Bruker Daltonics of Billerica, Mass., has developed a new mass spectrometry system that the company describes as a "holistic solution" for clinical proteomics and biomarker discovery. The ClinProt™ ...

Bruker's Biotyper enables molecular identification and taxonomical classification of bacteria, yeasts and fungi reliably and quickly using proteomic fingerprinting by high-throughput MALDI-TOF mass ...

Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...